Press release
Investigation announced for Long-Term Investors in shares of Viatris Inc. (NASDAQ: VTRS) over potential Wrongdoing
An investigation on behalf of current long term investors in Viatris Inc. (NASDAQ: VTRS) shares.
Investors who are current long term investors in Viatris Inc. (NASDAQ: VTRS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in Viatris Inc. (NASDAQ: VTRS stocks follows a lawsuit filed against Viatris Inc. (NASDAQ: VTRS over alleged securities laws violations. The investigation on behalf of current long term investors in Viatris Inc. (NASDAQ: VTRS stocks, concerns whether certain Viatris Inc. (NASDAQ: VTRS officers and directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Western District of Pennsylvania the plaintiff alleges that Viatris made materially false and/or misleading statements and/or failed to disclose that the Company was experiencing significantly more competition in its United States complex generics business than disclosed, that the Company was not able to effectively manage its base business erosion or create a stable revenue base, that despite being on the Company's only growth drivers, Viatris was actively planning to divest its biosimilars business in order to secure enough cash to let it purportedly meet its phase one goals, that Viatris was deviating from the business model it touted throughout the Class Period and undertaking a significant global reshaping of its business which would undermine its ability to achieve stable revenue growth, and that the Company was anticipating less financial growth moving into 2022.
Those who purchased shares of Viatris Inc. (NASDAQ: VTRS) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
Web: www.shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Viatris Inc. (NASDAQ: VTRS) over potential Wrongdoing here
News-ID: 4087310 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. ( …
An investor, who purchased shares of Molina Healthcare, Inc. (NYSE: MOH), filed a lawsuit over alleged violations of Federal Securities Laws by Molina Healthcare, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Molina Healthcare, Inc. (NYSE: MOH) have certain options and for certain investors are short and strict deadlines running. Deadline: December 02, 2025. NYSE: MOH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of p …
An investigation on behalf of current long-term investors in shares of CTO Realty Growth, Inc. (NYSE: CTO) concerning potential breaches of fiduciary duties by certain directors and officers of CTO Realty Growth, Inc. was announced.
Investors who are current long term investors in CTO Realty Growth, Inc. (NYSE: CTO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a…
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDA …
An investor, who purchased shares of Marex Group plc (NASDAQ: MRX), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Marex Group plc in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, have certain options…
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2 …
A deadline is coming up on October 27, 2025 in the lawsuit filed for certain investors of LifeMD, Inc. (NASDAQ: LFMD) over alleged securities laws violations by LifeMD, Inc.
Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and there are strict and short deadlines running. Deadline: October 27, 2025. LifeMD, Inc. (NASDAQ: LFMD) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Viatris
Abacavir Market is Booming Worldwide with GlaxoSmithKline, Viatris, Cipla
The latest study released on the Global Abacavir Market by HTF MI evaluates market size, trend, and forecast to 2031. The Abacavir market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This Report…
Naloxone Market Growth in Future Scope 2024-2031 | Akorn, Inc, Hikma Pharmaceuti …
The Latest research report on the Naloxone Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the Naloxone Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies, market dynamics, cost structures,…
Influenza Vaccines Industry May See a Big Move | BIKEN, Viatris, Sinovac Biotech
Data Insights Market published a new research publication on "Influenza Vaccines Industry Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Influenza Vaccines Industry was mainly driven by the increasing R&D spending across the world.
Some of the key players profiled in…
Motion Sickness Drugs Market Is Booming Worldwide | Hylands,Perrigo, Viatris
The "Motion Sickness Drugs Market" intelligence report, just published by USD Analytics Market, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Motion Sickness Drugs Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major…
Complex Regional Pain Syndrome Market Key Players | GlaxoSmithKline plc., Johnso …
As per the study initiated by Evolve Business Intelligence, the global Complex Regional Pain Syndrome Market size accounted for USD 102.3 Million in 2022, growing at a CAGR of 2.2% from 2023 to 2033. Complex Regional Pain Syndrome (CRPS) Market refers to the economic landscape associated with the diagnosis, treatment, and management of Complex Regional Pain Syndrome. CRPS is a chronic condition characterized by severe and prolonged pain, usually in…
Pulmonary Arterial Hypertension Market Is Booming Worldwide with Bayer, Sandoz, …
Pulmonary Arterial Hypertension Market latest research report added by USD Analytics. The Pulmonary Arterial Hypertension Market Study has been segmented by key a region that is accelerating the marketization. The report is a great blend of qualitative and quantitative market data that was gathered and evaluated mostly through primary data and secondary sources. This also provides the scope of different segments and applications that can potentially influence the marketplace in…
